Published in Appl Immunohistochem Mol Morphol on May 01, 2011
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma (ISG-MCS) | NCT04305548
Primary mesenchymal chondrosarcoma of the kidney with synchronous implant and infiltrating urothelial carcinoma of the ureter. Diagn Pathol (2012) 1.02
The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch (2014) 0.92
Small cell osteosarcoma of the mandible: Case report and review of its diagnostic aspects. J Oral Maxillofac Pathol (2011) 0.79
Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors. Am J Clin Pathol (2013) 0.76
Mesenchymal chondrosarcoma of the right buccal region: A case report and review of the literature. Oncol Lett (2014) 0.75
Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors. J Med Life (2015) 0.75
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma. Front Pharmacol (2017) 0.75
Detection of EWS/FLI-1 fusion in non-Ewing soft tissue tumors. J Med Life (2014) 0.75
Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. Virchows Arch (2014) 0.75
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf (2010) 5.80
Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol (2010) 5.25
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol (2004) 4.46
A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature (2012) 3.51
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer (2010) 2.81
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol (2008) 2.68
Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 2.35
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med (2011) 2.25
Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol (2007) 2.25
Annotation and query of tissue microarray data using the NCI Thesaurus. BMC Bioinformatics (2007) 2.03
The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res (2009) 2.00
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol (2008) 1.90
Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J Pathol (2012) 1.88
The fibromatosis signature defines a robust stromal response in breast carcinoma. Lab Invest (2008) 1.85
USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol (2004) 1.82
Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res (2004) 1.80
Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res (2008) 1.73
Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol (2008) 1.67
Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol (2003) 1.66
Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) (2010) 1.65
USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res (2004) 1.64
Validation of acute myocardial infarction cases in the national health insurance research database in taiwan. J Epidemiol (2014) 1.63
Idiopathic and diabetic skeletal muscle necrosis: evaluation by magnetic resonance imaging. Skeletal Radiol (2005) 1.62
Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol (2004) 1.61
High-resolution CT with histopathological correlates of the classic metaphyseal lesion of infant abuse. Pediatr Radiol (2014) 1.55
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2003. A nine-year-old girl with hepatosplenomegaly and pain in the thigh. N Engl J Med (2003) 1.51
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol (2012) 1.51
Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys (2006) 1.50
Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. Am J Pathol (2009) 1.48
Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. Arch Pathol Lab Med (2006) 1.47
Gastrointestinal stromal tumors: an ultrastructural study. Int J Surg Pathol (2002) 1.45
Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys (2007) 1.42
Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol (2010) 1.41
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med (2009) 1.41
Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases. J Bone Joint Surg Am (2006) 1.39
Metastatic myxoid liposarcomas: imaging and histopathologic findings. Skeletal Radiol (2007) 1.37
Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol (2002) 1.37
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol (2009) 1.33
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol (2010) 1.29
In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma. Cancer Cell (2012) 1.28
Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol (2008) 1.28
Epithelioid hemangioma of bone revisited: a study of 50 cases. Am J Surg Pathol (2009) 1.27
Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys (2008) 1.27
Update on bone forming tumors of the head and neck. Head Neck Pathol (2007) 1.25
Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol (2003) 1.25
Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One (2011) 1.24
Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol (2006) 1.23
The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol (2012) 1.23
Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol (2005) 1.22
Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol (2008) 1.22
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol (2012) 1.21
Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene (2005) 1.21
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One (2009) 1.18
Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res (2003) 1.18
Split tolerance to a composite tissue allograft in a swine model. Transplantation (2003) 1.18
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol (2014) 1.17
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res (2010) 1.16
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol (2015) 1.14
Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma. Am J Surg Pathol (2007) 1.14
The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Adv Anat Pathol (2010) 1.13
Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia. N Engl J Med (2011) 1.13
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. Am J Pathol (2011) 1.12
Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models. Bone (2010) 1.12
Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol (2010) 1.11
Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol (2006) 1.10
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan. Clin Ther (2008) 1.10
Management of acral myxoinflammatory fibroblastic sarcoma. Cancer (2010) 1.09
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (2009) 1.09
Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. Am J Surg Pathol (2013) 1.08
A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther (2009) 1.07
Organellar junctions promote targeted Ca2+ signaling in smooth muscle: why two membranes are better than one. Trends Pharmacol Sci (2004) 1.07
Aneurysmal bone cyst: a neoplasm driven by upregulation of the USP6 oncogene. J Clin Oncol (2006) 1.05
Case records of the Massachusetts General Hospital. Case 9-2008. A 65-year-old woman with a nonhealing ulcer of the jaw. N Engl J Med (2008) 1.05
Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels (2009) 1.03
Association of left atrial strain and strain rate assessed by speckle tracking echocardiography with paroxysmal atrial fibrillation. Echocardiography (2009) 1.03
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2010) 1.02
Soft tissue aneurysmal bone cyst: a clinicopathologic study of five cases. Am J Surg Pathol (2002) 1.01
Pre-uremic calciphylaxis. Iran J Kidney Dis (2014) 1.01
Protocol for the examination of specimens from patients with tumors of bone. Arch Pathol Lab Med (2010) 1.00
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas. Cancer (2011) 1.00
Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton. Am J Physiol Heart Circ Physiol (2004) 1.00
Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. Gynecol Oncol (2011) 0.99
Variations in stromal signatures in breast and colorectal cancer metastases. J Pathol (2010) 0.99
A renal cell carcinoma with components of both chromophobe and papillary carcinoma. Virchows Arch (2006) 0.99